Standout Papers

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection 2000 2026 2008 2017 5.0k
  1. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection (2002)
    Michael Fried, Mitchell L. Shiffman et al. New England Journal of Medicine
  2. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis (2015)
    Eduardo Vilar‐Gómez, Luis Calzadilla Bertot et al. Gastroenterology
  3. Peginterferon Alfa-2a in Patients with Chronic Hepatitis C (2000)
    Stefan Zeuzem, S.V. Feinman et al. New England Journal of Medicine
  4. Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B (2004)
    Patrick Marcellin, George Lau et al. New England Journal of Medicine
  5. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients (2005)
    Manuel Romero‐Gómez, María del Mar Viloria et al. Gastroenterology

Immediate Impact

14 by Nobel laureates 13 from Science/Nature 104 standout
Sub-graph 1 of 13

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Non-alcoholic fatty liver disease
2021 Standout

Works of M. Diago being referenced

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout

Author Peers

Author Last Decade Papers Cites
M. Diago 10440 10484 962 1128 130 12.4k
Marc G. Ghany 11694 12049 644 752 183 14.7k
Yasuji Arase 8947 8555 702 1034 392 11.4k
Jenny Heathcote 9697 9606 941 635 169 12.2k
P Opolon 9330 9074 993 681 161 11.8k
Mario Rizzetto 8247 10539 390 1627 299 12.7k
Tarik Asselah 9060 9046 680 413 284 11.7k
Tetsuya Hosaka 7134 7158 522 724 321 8.8k
Robert P. Perrillo 8284 8768 617 399 118 10.0k
Nizar N. Zein 5014 6420 563 1360 175 9.2k
Wan‐Long Chuang 8241 8122 603 545 504 10.8k

All Works

Loading papers...

Rankless by CCL
2026